Pharma News, 2020

Open Orphan and Codagenix have received approval from the UK’s independent Medicines and Healthcare Products Regulatory Agency (MHRA) to conduct a Phase I study of its COVID-19 vaccine.

The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a stro...

ZURICH (Reuters) - Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, res...

The United States has kicked off a massive logistical effort to distribute coronavirus vaccines across the country.

AstraZeneca has agreed to acquire US-based biopharmaceutical company Alexion Pharmaceuticals in a deal valued at $39bn.

ZURICH (Reuters) - Boehringer Ingelheim is paying 1.

Canada's health regulator has approved the Pfizer-BioNTech Covid-19 vaccine, the day after the UK became the first country in the world to roll it out.

Finding alternatives to antibiotics is one of the biggest challenges facing the research community.

Gilead Sciences Inc.

Gilead’s Yescarta has scored some promising interim results from a phase II study evaluating the chimeric antigen receptor (CAR) T therapy as a first-line treatment for high-risk large B-cel...

The US Food and Drug Administration (FDA) has granted Pfizer’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate a priority review for the prevention of pneumococcal diseas...

The U.